VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.05	19.93	30.62	30.91	42.25	57.56
Short-Term Investments	17.6	41.59	62.63	-	-	1.03
Cash & Short-Term Investments	39.65	61.52	93.25	30.91	42.25	58.59
Cash Growth	-49.24%	-34.03%	201.71%	-26.85%	-27.89%	-18.75%
Accounts Receivable	-	-	-	-	7.58	15.82
Other Receivables	-	-	-	5	-	-
Receivables	-	-	-	5	7.58	15.82
Inventory	-	-	-	-	-	7.4
Prepaid Expenses	4.7	2.92	2.66	2.3	4.57	4.59
Restricted Cash	-	-	0.05	0.07	0.61	0.86
Other Current Assets	-	-	-	-	8.18	-
Total Current Assets	44.34	64.44	95.96	38.28	63.19	87.26
Property, Plant & Equipment	0.13	0.21	0.21	-	0.35	2.14
Other Long-Term Assets	0.24	2.26	1.52	2.48	3.51	4.35
Total Assets	44.72	66.91	97.69	40.76	67.05	93.74
Accounts Payable	1.41	2.71	1.66	2.39	6.51	4.78
Accrued Expenses	4.4	8.59	3.51	4.26	6.06	10.32
Current Portion of Leases	0.03	0.1	0.12	-	0.35	0.76
Current Unearned Revenue	-	-	-	-	-	5.8
Other Current Liabilities	-	3.42	2.25	2.7	5.49	0.1
Total Current Liabilities	5.84	14.82	7.54	9.35	18.41	21.77
Long-Term Debt	-	-	-	-	-	33.17
Long-Term Leases	-	-	0.1	-	-	0.85
Other Long-Term Liabilities	-	-	1.31	-	-	0.46
Total Liabilities	5.84	14.82	8.95	9.35	18.41	56.25
Common Stock	0	0	0	-	0.01	0
Additional Paid-In Capital	784.42	783.24	780.04	693.94	688.16	603.69
Retained Earnings	-745.54	-731.17	-691.34	-662.74	-639.53	-566.2
Comprehensive Income & Other	-0	0.02	0.03	-	-	-
Total Common Equity	38.88	52.09	88.74	31.2	48.64	37.49
Shareholders' Equity	38.88	52.09	88.74	31.41	48.64	37.49
Total Liabilities & Equity	44.72	66.91	97.69	40.76	67.05	93.74
Total Debt	0.03	0.1	0.21	-	0.35	34.78
Net Cash (Debt)	39.62	61.42	93.04	30.91	41.9	23.81
Net Cash Growth	-49.17%	-33.99%	201.02%	-26.24%	76.01%	-36.75%
Net Cash Per Share	0.93	1.44	9.06	9.70	14.66	13.22
Filing Date Shares Outstanding	25.47	15.21	14.1	3.26	3.12	2.85
Total Common Shares Outstanding	19.77	14.83	14.1	3.23	2.98	2.4
Working Capital	38.51	49.62	88.43	28.93	44.78	65.49
Book Value Per Share	1.97	3.51	6.29	9.66	16.34	15.62
Tangible Book Value	38.88	52.09	88.74	31.2	48.64	37.49
Tangible Book Value Per Share	1.97	3.51	6.29	9.66	16.34	15.62
Machinery	0.12	0.12	-	-	0.85	0.94
Leasehold Improvements	-	-	-	-	0.06	0.06

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q